New eye treatment combo tested against standard therapy
NCT ID NCT07230184
Summary
This completed study tested whether adding a second drug (B55R2) to an existing treatment (B55R1) works better than using the single drug alone for diabetic retinopathy. Researchers followed 52 adults with non-proliferative diabetic retinopathy for 24 weeks, measuring changes in eye deposits and retinal thickness. The goal was to see if the combination therapy could better control this diabetes-related eye condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AJU Pharm Co., Ltd.
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.